Lisinopril
Zestril, Prinivil
Also known as: Pradaxa
Direct thrombin inhibitor, renally cleared. Anticoagulated: bleeding risk governs any invasive procedure.
Severity
Moderate caution
Mechanism
Other clinical interaction
Protocol Status
Continues — any change is the prescribing physician's decision, made before arrival
Restart Delay
Physician discretion
What "Moderate caution" Means
Use with caution. Often requires a brief hold, dose reduction, or enhanced monitoring rather than full discontinuation.
Clinical Action
Do NOT stop or hold on our initiative. Confirm the plan with the prescribing physician; renal function is relevant to clearance.
Where the Washout Happens
Continues — any change is the prescribing physician's decision, made before arrival
This medication is not stopped on our initiative and there is no washout interval we can set: what governs it is a clinical judgement that belongs to the prescribing physician, not a waiting period we can count. It is documented, flagged to the medical team, and the plan is confirmed with the prescriber BEFORE any invasive procedure or IV placement. Stopping an anticoagulant or antiplatelet without that conversation carries its own risk, which is why the default here is to continue and confirm rather than to hold.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
This class has clinical considerations that do not fit a single mechanism category. Review the specific risk and clinical action for handling, and discuss with the prescribing physician.
Same Mechanism
Same Severity Tier
QT-interval prolongation
Zofran
QT-interval prolongation
Zithromax, Z-Pack
Cardiac conduction (bradycardia / AV node)
Lopressor, Toprol
Cardiac conduction (bradycardia / AV node)
Tenormin
Cardiac conduction (bradycardia / AV node)
Inderal
Cardiac conduction (bradycardia / AV node)
Coreg
Common Questions
Moderate caution. Direct thrombin inhibitor, renally cleared. Anticoagulated: bleeding risk governs any invasive procedure. Do NOT stop or hold on our initiative. Confirm the plan with the prescribing physician; renal function is relevant to clearance.
Continues — any change is the prescribing physician's decision, made before arrival. This medication is not stopped on our initiative and there is no washout interval we can set: what governs it is a clinical judgement that belongs to the prescribing physician, not a waiting period we can count. It is documented, flagged to the medical team, and the plan is confirmed with the prescriber BEFORE any invasive procedure or IV placement. Stopping an anticoagulant or antiplatelet without that conversation carries its own risk, which is why the default here is to continue and confirm rather than to hold.
Other clinical interaction. This class has clinical considerations that do not fit a single mechanism category. Review the specific risk and clinical action for handling, and discuss with the prescribing physician.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Dabigatran — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 174 medications in the A–Z directory.